Advanced Enzyme Technologies reported Q4 FY26 consolidated revenue of ₹2,034 million, an 18% sequential growth.
Q4 PAT increased 69% YoY to ₹453 million, with EBITDA growing 28% QoQ to ₹632 million.
Human Nutrition remained the largest segment, contributing 63% to quarterly revenue and growing 20% YoY.
FY26 revenue reached ₹7,458 million, a 16% annual growth, with PAT at ₹1,736 million, up 30% YoY.